1-4 of 4
Anjali Franco
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Outcomes Following Dose Modifications of First-Line Ibrutinib in Patients with Waldenström Macroglobulinemia

Shayna R Sarosiek, Gottfried R. von Keudell, Jonas Paludo, Monika Salkar, Barnabie Agatep, Anjali Franco, Samuel Crawford, Michelle Pacia, Jorge J. Castillo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3780.
https://doi.org/10.1182/blood-2023-181925
Published: 2023
Journal Articles

Real-World Outcomes of Medicare Fee-for-Service Beneficiaries Meeting the Eligibility Criteria for the DREAMM-7 and DREAMM-8 Clinical Trials

Simon McNamara, Natalie Boytsov, Peter Feng Wang, Maya Hanna, Anjali Franco, Benjamin Lewing, Barth Kelly, Joseph Tkacz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1965.
https://doi.org/10.1182/blood-2023-181668
Published: 2023
Journal Articles

Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma

CME Clinical Trials & Observations
Dai Chihara, Laura Liao, Joseph Tkacz, Anjali Franco, Benjamin Lewing, Karl M. Kilgore, Loretta J. Nastoupil, Lei Chen
Journal: Blood
Blood (2023) 142 (12): 1047–1055.
https://doi.org/10.1182/blood.2023020197
Published: 2023
Includes: Supplemental data
Journal Articles

Real-World Effectiveness and Economic Impact Associated with Chimeric Antigen Receptor T-Cell Therapy Among Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in US

Dai Chihara, Laura Liao, Joseph Tkacz, Benjamin Lewing, Anjali Franco, Karl M. Kilgore, Loretta J. Nastoupil, Lei Chen
Journal: Blood
Blood (2022) 140 (Supplement 1): 2421–2423.
https://doi.org/10.1182/blood-2022-163678
Published: 2022